Literature DB >> 1985929

Functional characterization and receptor binding studies of the malic enzyme thyroid hormone response element.

B Desvergne1, K J Petty, V M Nikodem.   

Abstract

We previously showed that the 5'-flanking region of the malic enzyme (ME) gene contains a cis-regulatory element (-281 to -261) that binds thyroid hormone receptors and confers triiodothyronine (T3) inducibility of transcription to the ME promoter (Petty, K.J., Desvergne, B., Mitsuhashi, T., and Nikodem, V. M. (1990) J. Biol. Chem. 265, 7395-7400). In this report, we have used deletion and mutation analyses of the ME thyroid hormone response element (TRE) to evaluate the roles of several subregions of TRE in T3 binding and transactivation. ME TRE was shown to act as an enhancer conferring T3 responsiveness to a heterologous promoter thymidine kinase. Although T3 treatment induced the promoter activity, the absence of hormone resulted in repression as measured by the level of chloramphenicol acetyltransferase expression in the NIH 3T3 transient expression system in the presence of overexpressed receptor. The degree of repression was similar to the degree of T3 induction observed for the same TRE mutants. Mutation and deletion analyses indicated that the functional TRE is comprised of discrete regions that are not contiguous, with a dominant role of a cluster of G residues and an AGGACA sequence. Both functions, induction and repression of transcription, correlated with receptor binding to the ME TRE as determined by competition binding assays using wild type and mutated TRE as competitors.

Mesh:

Substances:

Year:  1991        PMID: 1985929

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Identification of thyroid regulatory elements in the Na-K-ATPase alpha3 gene promoter.

Authors:  M Bajpai; S K Mandal; S Chaudhury
Journal:  Mol Biol Rep       Date:  2001-03       Impact factor: 2.316

2.  Spot 14 protein interacts and co-operates with chicken ovalbumin upstream promoter-transcription factor 1 in the transcription of the L-type pyruvate kinase gene through a specificity protein 1 (Sp1) binding site.

Authors:  E Compe; G de Sousa; K François; R Roche; R Rahmani; J Torresani; M Raymondjean; R Planells
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

3.  The N-terminal region (A/B) of rat thyroid hormone receptors alpha 1, beta 1, but not beta 2 contains a strong thyroid hormone-dependent transactivation function.

Authors:  H Tomura; J Lazar; M Phyillaier; V M Nikodem
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

4.  Regulation of the mdm2 oncogene by thyroid hormone receptor.

Authors:  J S Qi; Y Yuan; V Desai-Yajnik; H H Samuels
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  A divergent role of COOH-terminal domains in Nurr1 and Nur77 transactivation.

Authors:  S O Castillo; Q Xiao; Z Kostrouch; B Dozin; V M Nikodem
Journal:  Gene Expr       Date:  1998

6.  The major transcription initiation site of the SV40 late promoter is a potent thyroid hormone response element.

Authors:  B Desvergne; T Favez
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

7.  Thyromimetic mode of action of peroxisome proliferators: activation of 'malic' enzyme gene transcription.

Authors:  R Hertz; V Nikodem; A Ben-Ishai; I Berman; J Bar-Tana
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

8.  Isolation of a thyroid hormone-responsive gene by immunoprecipitation of thyroid hormone receptor-DNA complexes.

Authors:  J Bigler; R N Eisenman
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

Review 9.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

10.  Analysis of thyroid response element activity during retinal development.

Authors:  Nathan A Billings; Mark M Emerson; Constance L Cepko
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.